These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1428500)

  • 1. Oral contraceptive 'potencies' and deep venous thromboembolism.
    Edgren RA
    Int J Epidemiol; 1992 Apr; 21(2):420-1. PubMed ID: 1428500
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraception and venous thromboembolism. A New Zealand perspective.
    Roke C
    Drug Saf; 1997 Feb; 16(2):79-87. PubMed ID: 9067120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changed routines in connection with first prescription of oral contraceptives. Lower risk of venous thromboembolism with levonorgestrel preparations].
    Milsom I; Odlind V; von Schoultz B; Ostlund I; Persson E
    Lakartidningen; 2002 Jan; 99(1-2):10-2, 15. PubMed ID: 11871161
    [No Abstract]   [Full Text] [Related]  

  • 4. Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives.
    Vandenbrouke JP; Bloemenkamp KW; Rosendaal FR; Helmerhorst FM
    BMJ; 2000 Jan; 320(7226):57-8. PubMed ID: 10671043
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboembolism and the combined oral contraceptive.
    Girard M
    Lancet; 1995 Jul; 346(8970):317. PubMed ID: 7677919
    [No Abstract]   [Full Text] [Related]  

  • 6. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
    Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
    Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolism associated with the new contraceptive Yasmin.
    van Grootheest K; Vrieling T
    BMJ; 2003 Feb; 326(7383):257. PubMed ID: 12560278
    [No Abstract]   [Full Text] [Related]  

  • 8. DoH seems to have underestimated incidence of venous thromboembolism in users of combined oral contraceptives.
    Lawrenson RA; Whalley A; Simpson E; Farmer RD
    BMJ; 1999 Aug; 319(7206):387. PubMed ID: 10435982
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral contraceptives and venous thromboembolism.
    Graham A; Grieve F; Davie J; Glasier A
    Lancet; 1995 Nov; 346(8987):1430. PubMed ID: 7475846
    [No Abstract]   [Full Text] [Related]  

  • 10. Desogestrel, gestodene contraceptives may carry greater thromboembolic risk.
    Am J Health Syst Pharm; 1996 Feb; 53(3):228. PubMed ID: 8808016
    [No Abstract]   [Full Text] [Related]  

  • 11. Thromboembolism and the combined oral contraceptive pill.
    Pasi KJ; Perry DJ; Lee CA
    Lancet; 1995 Jun; 345(8962):1437. PubMed ID: 7677845
    [No Abstract]   [Full Text] [Related]  

  • 12. Contraceptive pills and thrombosis: effects of the French crisis on prescriptions and consequences for medicine agencies.
    Emmerich J; Thomassin C; Zureik M
    J Thromb Haemost; 2014 Sep; 12(9):1388-90. PubMed ID: 25041638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and venous thromboembolism. New Zealand Committee, RANZCOG. Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
    N Z Med J; 2000 May; 113(1110):196. PubMed ID: 10917084
    [No Abstract]   [Full Text] [Related]  

  • 14. Third-generation oral contraceptives and venous thrombosis.
    Grant EC
    Lancet; 1997 Mar; 349(9053):733. PubMed ID: 9078228
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.
    Jick H
    BMJ; 2000 Jan; 320(7226):57; author reply 57-8. PubMed ID: 10617543
    [No Abstract]   [Full Text] [Related]  

  • 16. What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
    Meurer LN; Slawson JG
    J Fam Pract; 2001 Feb; 50(2):108. PubMed ID: 11219554
    [No Abstract]   [Full Text] [Related]  

  • 17. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
    Spitzer WO; Lewis MA; Heinemann LA; Thorogood M; MacRae KD
    BMJ; 1996 Jan; 312(7023):83-8. PubMed ID: 8555935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combined contraceptive pill.
    Szarewski A
    Practitioner; 2003 Jun; 247(1647):458, 461-6, 468-9. PubMed ID: 12822315
    [No Abstract]   [Full Text] [Related]  

  • 19. Combined oral contraceptives and thromboembolism.
    Rawlins M
    BMJ; 1995 Nov; 311(7014):1232. PubMed ID: 7488933
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Brenner P
    Contraception; 2006 Oct; 74(4):354; author reply 354-5. PubMed ID: 16982246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.